
Postdoctoral Researcher @ImperialBiz | PhD @LSEHealthPolicy
London
Joined June 2022
- Tweets124
- Following405
- Followers147
- Likes648
Arianna Gentilini retweeted
𝐖𝐡𝐲 𝐂𝐨𝐫𝐫𝐮𝐩𝐭𝐢𝐨𝐧 𝐏𝐞𝐫𝐬𝐢𝐬𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐞𝐜𝐭𝐨𝐫 💰
Corruption drains budgets, erodes trust & fuels inequality in Europe’s health systems.
Why does it persist?
👉 Read Iva Parvanova’s blog here: bit.ly/43YOScF
Arianna Gentilini retweeted
🚨 Job Alert 🚨
4-year postdoc position to work on my ERC project HARSH - Uncovering the Roots of Harsh Parenting.
📍 Dep. of Economics @DSE_Unibo, Bologna, Italy 🇮🇹
📅 Deadline: March 14, 2025
💡 Learn more and apply here: econjobmarket.org/positions/…
#econtwitter #econjobmarket #ejm
Arianna Gentilini retweeted
✨Chuffed to have won the best presentation at @UUUIPS Winter Meeting.
Was a great time hearing about different projects at all different cross-sections and meet the policy faculty.
@LSEHealthPolicy
1/ 📢 New paper out today in the Eur J Health Econ with Alina Rana!
We reviewed patient submissions to 15 NICE Highly Specialised Technology appraisals to see how patient voices are considered in decision-making.
Full article below 👇🏼
link.springer.com/article/10…
Arianna Gentilini retweeted
New paper by @IvaParvanova01 & @mylene_lagarde examines how survey wording affects bribery rates in #healthcare.💰Loaded (corruption-linked) vs neutral (payments/gifts) wording reveals notable differences across countries.🔗bit.ly/3Zth1Gt
#InternationalAntiCorruptionDay
Arianna Gentilini retweeted
In this latest work, @KanavosPG et al from @LSEHealthPolicy provide a validation exercise on the use of @myESMO #MCBS as a tool to aid in decision-making for #cancer drugs. #HTA
A next step toward #value -based healthcare, more to come on this! ✔️
@VriesElisabeth
thelancet.com/journals/lanon…
Great study by @KanavosPG @aris_angelis and Erica Visintin on the use of @myESMO in #HTA recommendations.
cc: @LSEHealthPolicy
Arianna Gentilini retweeted
🚨New Research by @IvaParvanova01 & @agentilini_ on the EU's 24 COI regulation in JCA. 🌟
📊 Key findings:
✔️Progress in transparency for EU-wide HTAs.
✔️Concerns on expert diversity & COI enforcement.
✔️Recs for stronger accountability.
🔗Read now👇bmjopen.bmj.com/content/14/1…
New article w/ @IvaParvanova01 out in @BMJ_Open! 👇🏻
Congratulations to Dr Arianna Gentilini [@agentilini_] whose paper 'Managing experts’ conflicts of interest in the EU Joint Clinical Assessment' has been published in @BMJ_Open 👏 👏 👏
Read the paper: imprl.biz/3ASHyoy
#IBResearch
6
117
Arianna Gentilini retweeted
🚨@agentilini_ and I analyze the new COI regulation for EU HTA (#JCA) @BMJ_Open, key points:
✍️No guidance for disclosing the size of financial interests
⚖️No COI mitigation for experts from conflicted orgs or conflicted experts (esp for rare diseases)
👉tinyurl.com/j5y6zkau
Arianna Gentilini retweeted
UK patient organisations took €20m from drug companies in 2022, followed by groups in Belgium, France, Italy and Germany. In a first Europe-wide study, our investigation reveals 11,000+ payments made by pharma industry to advocacy groups and charities: investigate-europe.eu/posts/…
Arianna Gentilini retweeted
Also in the Aug issue:
Clinical benefit, reimbursement outcomes, and prices of FDA-approved #cancerdrugs reviewed through #ProjectOrbis in the #USA, #Canada, #England, and #Scotland: a retrospective, comparative analysis
thelancet.com/journals/lanon…
Arianna Gentilini retweeted
Access to medicines is a critical indicator of progress towards the SDGs and should not be dropped. Read our recommendations how to strengthen investment in measurement #IAEG Inter-Agency —Expert Group on #SDGs Indicators (IAEG-SDGs) @kjmeetswrld @UNStats ncbi.nlm.nih.gov/pmc/article…
Arianna Gentilini retweeted
New publication @TheLancet Oncology by @kjmeetswrld & @agentilini_ examines the clinical benefit, #HTA review times & drug #prices reviewed through #ProjectOrbis, an initiative to streamline regulatory review across international regulators.🔗Read now: bit.ly/45ZFJ48














